Kusuri No Aoki HoldingsTSE:3549 -0.79%92 EBITDA Margin % is 10.02% as of Nov. 2025, which is 28% above its 10-year median of 7.83. GuruFocus rates TSE:3549 with a GF Score™ of 92/100 and a GF Value™ of 円4,067.87 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Kusuri No Aoki Holdings ranks worse than 54.19% on this metric.
Kusuri No Aoki Holdings (TSE:3549) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Kusuri No Aoki Holdings EBITDA Margin % Related Terms
Kusuri No Aoki Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kusuri No Aoki Holdings EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Kusuri No Aoki Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kusuri No Aoki Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kusuri No Aoki Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Kusuri No Aoki Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kusuri No Aoki Holdings (TSE:3549) has a EBITDA Margin % of 10.02% as of Nov. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kusuri No Aoki Holdings and its competitors. This is 28% above median its historical median of 7.83. Over the past decade, Kusuri No Aoki Holdings' EBITDA Margin % has ranged from 7.24 to 8.76. According to the industry distribution chart, Kusuri No Aoki Holdings ranks #362 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 54.2%.
Is Kusuri No Aoki Holdings' EBITDA Margin % too high?
Kusuri No Aoki Holdings' current EBITDA Margin % of 10.02% is 28% above median its 10-year median of 7.83. Over the past 10 years, this metric has ranged from a low of 7.24 to a high of 8.76. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Kusuri No Aoki Holdings' value of 10.02% is 1.9% below this industry median. Based on the distribution chart, Kusuri No Aoki Holdings ranks #362 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Kusuri No Aoki Holdings has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kusuri No Aoki Holdings' EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Kusuri No Aoki Holdings ranks #362 out of 668 companies for EBITDA Margin %. This places Kusuri No Aoki Holdings in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Kusuri No Aoki Holdings' value of 10.02% is 1.9% below this benchmark. Historically, Kusuri No Aoki Holdings' own EBITDA Margin % has ranged from 7.24 to 8.76 over the past decade. While the company's 10-year median is 7.83 vs. the industry median of 10.21, Kusuri No Aoki Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kusuri No Aoki Holdings's current EBITDA Margin % of 10.02% is 1.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kusuri No Aoki Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kusuri No Aoki Holdings's current EBITDA Margin % is 10.02%, which is 28% above median its own 10-year median of 7.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kusuri No Aoki Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kusuri No Aoki Holdings (TSE:3549) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,067.87, compared to a current price of 円3,533.00 — trading 13.1% below its estimated fair value. The current EBITDA Margin % is 10.02%, which is 28% above median its 10-year median of 7.83 and 1.9% below the Healthcare Providers & Services industry median of 10.21. Kusuri No Aoki Holdings' overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Kusuri No Aoki Holdings (TSE:3549), the current EBITDA Margin % is 10.02% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kusuri No Aoki Holdings (TSE:3549) Overvalued in 2026?
Based on GuruFocus' analysis, Kusuri No Aoki Holdings stock appears to be undervalued.
The current stock price of 円3,533.00 is trading 13.1% below its estimated GF Value™ of 円4,067.87.
GuruFocus considers Kusuri No Aoki Holdings to be Modestly Undervalued.
Key valuation signals for TSE:3549:
EBITDA Margin %: 10.02% (28% above median its 10-year median of 7.83)
GF Value™: 円4,067.87 vs. price of 円3,533.00 (13.1% below fair value)
Industry Position: 1.9% below the Healthcare Providers & Services median (#362 of 668)
No single metric tells the full story. See the TSE:3549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kusuri No Aoki Holdings is a pharmaceutical retail chain that sells health, beauty, and cleaning supplies. The company operates stores that focus primarily on residential areas in Japan. Kusuri's business includes pharmaceutical drugs, and the company also operates a bone-marrow bank. The company breaks out its sales into four different product lines, including health, beauty, life, and dispensing. The vast majority of the company's revenue is derived from its life product category, followed by beauty products. Most of Kusuri's revenue is derived from the Hokuriku region.
92GF Score
Get the complete analysis for TSE:3549
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3549 has been successfully added to your 
